Research·2026-03-14·3 min read

Older Adults Find Better Pain Relief and Fewer Side Effects with CBD Cannabis Extracts Over THC

New real-world data from Germany's Pain e-Registry reveals CBD-dominant cannabis extracts offer superior pain management with fewer adverse effects compared to THC in older chronic pain patients.

By Editorial Team
Link Copied!

Key Takeaways

  • CBD-dominant cannabis extracts showed better effectiveness for chronic pain relief in older adults compared to THC/Dronabinol
  • Patients using CBD experienced significantly fewer side effects, making it potentially safer for older adults with multiple health conditions
  • Real-world data from 24 weeks of treatment supports cannabis-based medicines as viable alternatives when traditional pain medications pose risks
  • The study addresses a critical gap in pain management for older adults who face limited safe treatment options due to comorbidities and medication interactions

Managing chronic pain in older adults has long been one of medicine's most challenging puzzles. Traditional pain medications often come with serious risks — from addiction potential to dangerous interactions with other medications that seniors commonly take. Now, groundbreaking research from Germany's comprehensive Pain e-Registry suggests that cannabis-based medicines, particularly CBD-dominant extracts, may offer a safer and more effective path forward for older patients struggling with persistent pain.

Key Finding

CBD-dominant oral cannabis extracts demonstrated superior effectiveness and safety compared to THC/Dronabinol in older chronic pain patients over 24 weeks of real-world treatment

This represents the first large-scale comparison of different cannabis formulations specifically in older adults with chronic pain conditions

The Growing Crisis of Pain Management in Aging Populations

Chronic pain affects nearly 50% of older adults, yet treating it safely becomes increasingly complex with age. The presence of multiple health conditions — what doctors call comorbidities — means that traditional pain relievers like opioids, NSAIDs, and even some antidepressants can trigger dangerous side effects or interact with other essential medications.

This therapeutic dilemma has left many older patients caught between inadequate pain control and medication risks. The severity of their symptoms contrasts sharply with the limited safe treatment options available, creating an urgent need for alternative approaches that can provide relief without compromising overall health.

Real-World Evidence from Germany's Comprehensive Pain Database

The CARE study drew from Germany's Pain e-Registry, a comprehensive database that tracks real-world outcomes for patients receiving cannabis-based treatments. Researchers followed two groups of older adults with chronic pain over 24 weeks, comparing those treated with CBD-dominant oral extracts against those receiving THC/Dronabinol.

This retrospective, dual-cohort design allowed researchers to examine how these treatments perform outside the controlled environment of clinical trials — capturing the messy reality of how older patients with multiple health conditions actually respond to cannabis-based medicines in everyday clinical practice.

CBD vs. THC Cannabis Treatment Outcomes in Older Adults

Treatment AspectCBD-Dominant ExtractsTHC/Dronabinol
Pain Relief EffectivenessSuperior improvementModerate improvement
Side Effect ProfileSignificantly fewer adverse eventsMore frequent side effects
Treatment ToleranceBetter long-term adherenceHigher discontinuation rates
Safety in ComorbiditiesLower risk interactionsIncreased monitoring needed

Debunking the 'More THC Equals Better Pain Relief' Misconception

A persistent misconception in cannabis medicine assumes that THC — the psychoactive component that produces a 'high' — is always more effective for pain relief. This study challenges that assumption, particularly for older adults. The research revealed that CBD-dominant formulations actually provided superior pain management outcomes compared to THC-heavy alternatives.

This finding has crucial implications for older patients, who may be more sensitive to THC's cognitive and cardiovascular effects. CBD offers anti-inflammatory and pain-relieving properties without the intoxicating effects that can increase fall risk, confusion, or medication interactions in this vulnerable population.

What These Findings Mean for Your Pain Management Options

If you're an older adult struggling with chronic pain, this research suggests that CBD-dominant cannabis medicines might offer a safer alternative to traditional pain medications. The 24-week timeframe of this study demonstrates that these benefits can be sustained over months, not just weeks.

The superior safety profile of CBD-dominant formulations is particularly relevant if you're taking multiple medications or have conditions like heart disease, kidney problems, or cognitive concerns. Unlike opioids or NSAIDs, CBD appears to work through different pathways that don't interfere with many common medications older adults require.

Questions to Discuss with Your Healthcare Provider

Before considering cannabis-based treatments, prepare these questions for your next appointment:

  • Given my current medications and health conditions, would CBD-dominant cannabis extracts be safer than my current pain management approach?
  • How would we monitor my response to cannabis-based treatment, and what signs should I watch for?
  • Are there any specific interactions between CBD and my current medications that we need to consider?
  • What dosing approach would be most appropriate for someone with my health profile and pain levels?

Key Insight for Older Adults

Cannabis-based medicines may offer an important middle ground for older adults who need effective pain relief but face too many risks with conventional medications. The real-world evidence suggests CBD-dominant formulations can provide sustained pain management with fewer adverse effects than both traditional pain medications and THC-based cannabis products.

Important Study Limitations to Consider

This research, while promising, has several important limitations. As a retrospective study, it relied on existing medical records rather than controlled clinical conditions. The specific dosing regimens, exact CBD-to-THC ratios, and patient selection criteria weren't standardized. Additionally, the study was conducted within Germany's healthcare system, so results may not directly translate to other countries with different cannabis regulations and medical practices. Long-term effects beyond 24 weeks remain unknown, and more research is needed to establish optimal dosing guidelines for different types of chronic pain in older adults.

This research represents a significant step forward in understanding how cannabis-based medicines can safely serve older adults with chronic pain. As regulatory frameworks continue evolving and more real-world data becomes available, CBD-dominant formulations may become increasingly important tools in the challenging landscape of geriatric pain management. The next phase of research will likely focus on establishing standardized protocols and identifying which specific chronic pain conditions respond best to different cannabis formulations in older populations.

Sources & References

  1. Überall MA, Müller-Schwefe PCG, Küster MA, Müller-Schwefe GHH. "CARE - A Retrospective, Dual-Cohort, 24-Week Real-World Study from the German Pain e-Registry on the Effectiveness and Safety of CBD-Dominant Oral Cannabis Extracts versus THC/Dronabinol in Older Patients with Chronic Pain." - Journal of pain research (2026)

Medical Disclaimer: The information provided on ChronicRelief.org is intended for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.